Swiss cannabis and hemp trade: evidence and limits
What evidence is needed for cannabis trade statistics? Volumes, country shares and the trade balance are not established in this evidence base. Customs extracts and authorisations must be distinguished.
Key facts
- 2025 hemp/CBD export volume: Not established here
- Country shares of exports: Not established here
- 2025 medical cannabis import volume: Not established here
Key takeaways
- A customs catalogue alone does not substantiate a cannabis-specific volume.
- Authorised, requested and actually traded amounts must not be equated.
- The retained country fields are not a ranking of leading export markets.
Interpretation
A meaningful trade balance requires comparable import and export observations. Tonnes of raw material, kilograms of an active substance and the monetary value of finished goods are not interchangeable. Nor should a tariff position be described without verification as the CBD market, medical cannabis or Swiss production. Even a correctly measured flow does not explain its causes: demand, certification costs or the effects of foreign laws require additional evidence. This page therefore distinguishes access to official sources from a statistical analysis still to be established. The table retains the previous comparison fields without confirming their market standing or an export surplus. Every future number must be traceable to the same documented coverage.
Limitations
- No traceably extracted cannabis-specific annual series. Missing trade volume is not zero.
- The retained country fields are neither exhaustive nor confirmed as market shares.
- This data review is not a complete guide to commercial or personal imports and exports.
Data
| Previously listed comparison area | Substantiated export share |
|---|---|
| Germany | Not established here |
| Austria | Not established here |
| Italy | Not established here |
| Poland | Not established here |
| Other EU countries | Not established here |
Methodology
The FOCBS catalogue describes foreign trade by tariff number and mode of transport, with provisional monthly data and definitive historical data on request. It is a starting point for analysis, not evidence for the cannabis volumes previously shown here. A reproducible extract must document the period, goods coverage, tariff version, unit, flow direction and partner country. A tariff position should be used as a cannabis or CBD measure only after checking its actual goods coverage. No such traceable extract is established here, so the former annual curve and export shares are not retained as observations. Swissmedic provides documents for import and export applications concerning controlled substances. Applications, authorisations, quotas and amounts actually traded are different measures. This overview does not replace an authorisation assessment or constitute a complete trade census.
Sources
- FOCBS: foreign trade by tariff number and mode of transport — BAZG / OFDF / UDSC / FOCBS
- Swissmedic: imports and exports of controlled substances — Swissmedic
Related data & articles
Parent
Related datasets
- Medical cannabis in Switzerland: MeCanna notifications 2022–2023 — Dataset · Medical
- Swiss cannabis market size: evidence and limitations — Dataset · Market
Matching knowledge hubs
- Cannabis statistics Switzerland — Knowledge hub
- CBD — The complete Switzerland hub — Knowledge hub
Articles
No traceably extracted cannabis-specific annual series. Missing trade volume is not zero.